Medical News from Reuters Health News

Israel's Gamida Cell raises $40 million for bone marrow trial

June 18, 2017, 11:32 am by Reuters Health News

TEL AVIV (Reuters) - Israel's Gamida Cell, which is developing cellular therapies to treat cancer and rare genetic diseases, said on Monday it raised $40 million to finance the advanced trial of its product NiCord to facilitate bone marrow transplants.

Featured Medical Stories

Newest Fitbits

Have you seen the NEW FITBIT??

Fitbit is now a health tracker and fasion statement. See all the new beautiful models here >> See the HOTTEST new Fitbits!

See the HOT Fitbit Blaze Now Compare All Fitbit Products Google Fitbit
Sense Sleep Tracker

Awaken Your Sleeping Beauty With This Sleep Tracker

Sleep is the new hot topic and from what science tells us, it is the holy grail of health. If you can track it, you can optimize it. If you can optimize it, you can benefit from it. This hot new sleep tracker by Hello is the perfect sleep tracker for the perfect price. There is beauty in health, and it needs to be awakened. But before that, let's get the best sleep of our lives. Learn more here: Sense Sleep Tracker on Amazon

Sleep Tracker on Amazon Sleep Tracker Reviews Google Sleep Trackers

More medical news from Reuters Health News

Caffeine in pregnancy tied to childhood weight gain
Reuters Health News : April 24, 2018, 12:56 pm
(Reuters Health) - Pregnant women who drink lots of coffee and other caffeinated beverages may be more likely to have kids who are overweight than mothers who limit caffeine during pregnancy, a Norwegian study suggests.

For elderly, opioids tied to higher risk of fall-related injuries and deaths
Reuters Health News : April 24, 2018, 12:37 pm
(Reuters Health) - Elderly people who are prescribed opioids may be at higher risk for injuries from falls, some of which may be fatal, a Canadian analysis of trauma cases suggests.

Ex-Roche scientist Reed to head Sanofi R&D as Zerhouni retires
Reuters Health News : April 24, 2018, 12:29 pm
(Reuters) - Sanofi said on Tuesday it had hired former Roche top scientist John Reed to head its research operations from July 1, when Elias Zerhouni retires from the French drugmaker.

Novartis' digital drive continues with eye-disease app
Reuters Health News : April 24, 2018, 11:36 am
ZURICH (Reuters) - Novartis's foray into digital technology intensified on Wednesday as the Swiss drugmaker launched a mobile-phone based app to help collect data from people participating in eye disease studies.

Express Scripts targets Amgen, Lilly migraine drugs in pricing shift
Reuters Health News : April 24, 2018, 11:35 am
LOS ANGELES (Reuters) - The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken, and taking aim at Amgen Inc, Eli Lilly and Co and other makers of new migraine medicines to try and fix it.